Protective effect of TA-993, a novel therapeutic agent for peripheral circulatory insufficiency, on skeletal muscle fatigue in a rat model of hindlimb ischemia

Japanese Journal of Pharmacology

Volumn 83, Issue 1, 2000, Pages 73-81

  Doi, Hisayoshi ^a   Kaburaki, Minako ^a   Inoue, Hirotaka ^a   Suzumura, Kuniharu ^a   Narita, Hiroshi ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Blood flow; Intermittent claudication; Skeletal muscle; TA 993

Indexed keywords

3 ACETOXY 5 [2 (DIMETHYLAMINO)ETHYL] 2,3 DIHYDRO 8 METHYL 2 (4 METHYLPHENYL) 1,5 BENZOTHIAZEPIN 4(5H) ONE MALEATE; BENZOTHIAZEPINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL DISEASE; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE DEFORMABILITY; INTERMITTENT CLAUDICATION; LIMB BLOOD FLOW; LIMB ISCHEMIA; MUSCLE CONTRACTION; MUSCLE FATIGUE; NONHUMAN; RAT; SKELETAL MUSCLE;

ANIMALS; BLOOD PRESSURE; BLOOD VISCOSITY; DILTIAZEM; HEART RATE; HINDLIMB; ISCHEMIA; MUSCLE FATIGUE; PENTOXIFYLLINE; PLATELET AGGREGATION INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW;

EID: 0034045093     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.83.73     Document Type: Article

References (19)

1. Gillings DB: Pentoxifylline and intermittent claudication: Review of clinical trials and cost-effectiveness analyses. J Cardiovasc Pharmacol 25, Suppl 2, S44-S50 (1995)
2. Ponte E and Cattinelli S: Quality of life in a group of patients with intermittent claudication. Angiology 47, 247-251 (1996)
3. Kent KC, Donaldson MC, Attinger CE, Couch NP, Mannick JA and Whittemore AD: Femoropopliteal reconstruction for claudication: The risk to life and limb. Arch Surg 123, 1196-1198 (1988)
4. Larsen OA and Larsen NA: Effects of daily muscular exercise in patients with intermittent claudication. Lancet II, 1093-1095 (1966)
5. Newham DJ, McPhail G, Mills KR and Edwards RH: Ultrastructural changes after concentric and eccentric contractions of human muscle. J Neurol Sci 61, 109-122 (1983)
6. Warhol MJ, Siegel AJ, Evans WJ and Silverman L: Skeletal muscle injury and repair in marathon runners after competition. Am J Pathol 18, 331-339 (1985)
7. Friden J, Seger J and Ekblom B: Sublethal muscle fibre injuries after high tension anaerobic exercise. Eur J Appl Physiol 57, 360-368 (1988)
8. Sjöström M: Muscle fine structure and less advanced ischemia. In Induced Skeletal Muscle Ischaemia in Man, Edited by Lewis, DH, p 80, Karger, Basel (1982)
9. Ciocon JO, Galindo CD and Galindo DJ: A comparison between aspirin and pentoxifylline in relieving claudication due to peripheral disease in the elderly. Angiology 48, 237-240 (1997)
10. Kaburaki M, Narita H, Yabana H, Karasawa T, Doi H and Murata S: Cardiovascular effect of a new 1,5-benzothiazepine derivative TA-993 in anesthetized dogs. J Cardiovasc Pharmacol 31, 240-247 (1998)
11. Odawara A, Kikkawa K, Katoh M, Toryu, Shimazaki T and Sasaki Y: Inhibitory effects of TA-993, a new 1,5-benzothiazepine derivative, on platelet aggregation. Circ Res 78, 643-649 (1996)
12. Trezise DJ, Drew GM, Roach AG, Watts IS and Weston AH: Cromakalim does not protect against skeletal muscle fatigue in an anaesthetized rat model of acute hindlimb ischemia. Eur J Pharmacol 250, 109-116 (1993)
13. Denis LC and John TS: Vascular Disease in the Limbs: Mechanism and Principles of Treatment. George Stamathis, St. Louis (1994)
14. Nishio S, Yamada N, Endoh T, Isogaya M, Fukatsu Y, Nishimura S, Kanai N and Umetsu T: Effect of beraprost sodium on peripheral circulatory disturbances induced by various stimuli. Arzneimittelforschung 39, 1229-1234 (1989)
15. Samlaska CP and Winfield EA: Pentoxifylline. J Am Acad Dermatol 30, 603-621 (1994)
16. Yao JS: New techniques in objective arterial evaluation. Arch Surg 106, 600-604 (1973)
17. Ohta T, Sugimoto I, Hida K, Kato R and Thuchioka H: Physical training or medical treatment in patients with intermittent claudication: observation of the walking ability and limb hemodynamics in a short-term program. Myakkangaku 35, 429-435 (1995) (text in Japanese with English abstract)
18. Alfred GG, Louis SG, Theodore WR and Ferid M: The Pharmacological Basis of Therapeutics, pp 680-689, Macmillan Publishing Company, New York (1985)
19. Kaburaki M, Yabana H, Doi H, Nagata K, Narita H and Murata S: The mechanism of the increasing action of TA-993, a new 1,5-benzothiazepine derivative, on limb blood flow anesthetized dogs: selective suppression of sympathetic nerve activity. J Pharmacol Exp Ther 288, 1167-1173 (1999)